Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

ASCO '13 Preview: Gilead's Big Cancer Debut
TheStreet.com
Thursday, May 16, 2013 - 8:54am
tags:
Gilead, ASCO, JNJ, Pharmacyclics, idelalisab, ibrutinib, CLL
The Ranbaxy Whistleblower And The Scheme To Fool The FDA
Pharmalot
Thursday, May 16, 2013 - 8:51am
tags:
whistleblower lawsuits, Ranbaxy, FDA
Why The Medicines Company May Be About to Take Off
Motley Fool
Thursday, May 16, 2013 - 8:50am
tags:
Medicines Company
Bristol-Myers Drug Cocktail Stymies Melanoma Tumors
Bloomberg
Thursday, May 16, 2013 - 8:49am
tags:
melanoma, Bristol-Myers Squibb, nivolumab, Yervoy
J&J Wins Expanded Approval of Simponi for Bowel Disease
Bloomberg
Wednesday, May 15, 2013 - 5:15pm
tags:
Simponi, JNJ, FDA, inflammatory bowel disease
Roche exploring sale of diabetes device unit
Yahoo/Reuters
Wednesday, May 15, 2013 - 5:14pm
tags:
Roche, devices, diabetes, blood glucose monitoring
New Data On Boston Scientific's Atrial Fibrillation Watchman Device Could Lift Outlook
Seeking Alpha
Wednesday, May 15, 2013 - 3:00pm
tags:
atrial fibrilation, WATCHMAN, devices, Boston Scientific
Contraceptive Ring: Another Under-The-Radar Catalyst For Antares
Seeking Alpha
Wednesday, May 15, 2013 - 2:58pm
tags:
Nestragel, Nestorone, contraceptives, contraceptive rings, Antares, devices
Bovie's J-Plasma May Slay The MRSA Dragon (And Other Nasties)
Seeking Alpha
Wednesday, May 15, 2013 - 2:54pm
tags:
J-plasma, MRSA, Bovie Medical, devices
Nektar Posts Wider Loss, Maintains View
Yahoo/Zacks
Wednesday, May 15, 2013 - 2:52pm
tags:
earnings, Nektar
Bayer, Algeta Win U.S. Approval for Prostate Cancer Drug
Bloomberg
Wednesday, May 15, 2013 - 2:51pm
tags:
Bayer, Algeta, FDA, prostate cancer, Xofigo
5 Stocks Boosting The Drugs Industry Higher
TheStreet.com
Wednesday, May 15, 2013 - 2:50pm
tags:
Gilead, Bristol-Myers Squibb, JNJ, Merck, Pfizer
Bristol-Myers Targets Heart-Failure Drugs in R&D Effort
Bloomberg
Wednesday, May 15, 2013 - 2:48pm
tags:
heart failure, Bristol-Myers Squibb, R&D
Actavis Said to Have Spurned $15 Billion Offer From Mylan
Bloomberg
Wednesday, May 15, 2013 - 10:44am
tags:
Actavis, M&A, Mylan
A Few Hundred More Pharma Jobs Are Being Cut
Pharmalot
Wednesday, May 15, 2013 - 10:43am
tags:
layoffs, Purdue Pharma, Astellas, OSI Pharmaceuticals, Intermezzo, contract reps
J&J Gets A Shot In The Arm From WHO Over Vaccine Deaths
Pharmalot
Wednesday, May 15, 2013 - 10:42am
tags:
JNJ, vaccine, WHO
Amarin & Celsion: Post-Earnings Roundup
Seeking Alpha
Wednesday, May 15, 2013 - 10:40am
tags:
earnings, Amarin, Celsion
Wider-Than-Expected Loss at Athersys
Yahoo/Zacks
Wednesday, May 15, 2013 - 10:40am
tags:
earnings, Athersys
Aveo Screwed Up but Its Kidney Cancer Drug Is Real
TheStreet.com
Wednesday, May 15, 2013 - 10:37am
tags:
kidney cancer, Aveo Oncology, tivozanib
Will Obesity Drugs Gain Soon?
Motley Fool
Wednesday, May 15, 2013 - 9:50am
tags:
obesity, Novo Nordisk, Arena Pharmaceuticals, Vivus, Orexigen, Belviq, Contrave, Qsymia, Victoza

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.